Literature DB >> 28795902

Rhabdomyosarcoma of the breast: Report of a rare malignancy.

Yufen Yuan1, Junna Hou2, Yunbao Pan3,4.   

Abstract

Rhabdomyosarcoma (RMS) is an uncommon type of soft-tissue malignancy which mainly influences children. RMS rarely occurs in breast and little of the clinical behavior and treatment strategies were reported. Here, we describe a case of adult female patient with breast RMS. A 34-years-old Chinese woman visited to our hospital complaining palpable mass in her left breast. Seven months ago, the patient was diagnosed as lymphocytic mastitis and received surgical excision in the left breast. Five months later, she noticed a palpable mass again in the left breast. Ultrasonography suspected a malignant lesion and a diagnosis of RMS was made after segmental mastectomy and immunohistochemical staining. Therapy consisted of mastectomy and following neoadjuvant chemotherapy. The patient has remained disease free 30 months post-operatively. We should consider RMS when we see a breast mass. Tissue biopsy and immunohistochemical staining are recommended for diagnosis of RMS in young women. Oncologists should take immediate and active treatment on RMS.

Entities:  

Keywords:  Rhabdomyosarcoma; breast; breast cancer; immunohistochemical staining

Mesh:

Substances:

Year:  2017        PMID: 28795902      PMCID: PMC5663407          DOI: 10.1080/15384047.2017.1360440

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  17 in total

1.  Evidence of "stage shift" in IRS studies?

Authors:  J Pritchard
Journal:  J Clin Oncol       Date:  1990-10       Impact factor: 44.544

Review 2.  Rhabdomyosarcoma of the Breast in Adolescent and Young Adult (AYA) Women.

Authors:  Anthony N Audino; Bhuvana A Setty; Nicholas D Yeager
Journal:  J Pediatr Hematol Oncol       Date:  2017-01       Impact factor: 1.289

3.  Primary and metastatic rhabdomyosarcoma in the breast: neoplasms of adolescent females, a report from the Intergroup Rhabdomyosarcoma Study.

Authors:  D M Hays; S S Donaldson; H Shimada; W M Crist; W A Newton; R J Andrassy; E Wiener; J Green; T Triche; H M Maurer
Journal:  Med Pediatr Oncol       Date:  1997-09

4.  Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass.

Authors:  P Dias; B Chen; B Dilday; H Palmer; H Hosoi; S Singh; C Wu; X Li; J Thompson; D Parham; S Qualman; P Houghton
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

5.  Radiation therapy may increase metastatic potential in alveolar rhabdomyosarcoma.

Authors:  Gary M Woods; Kathryn Bondra; Christopher Chronowski; Justin Leasure; Mamata Singh; Lauren Hensley; Timothy P Cripe; Arnab Chakravarti; Peter Houghton
Journal:  Pediatr Blood Cancer       Date:  2015-03-19       Impact factor: 3.167

6.  Primary and metastatic rhabdomyosarcoma in the breast: report of two pediatric cases.

Authors:  F Binokay; S K Soyupak; M Inal; M Celiktas; E Akgül; E Aksungur
Journal:  Eur J Radiol       Date:  2003-12       Impact factor: 3.528

Review 7.  Nonepithelial malignancies of the breast.

Authors:  Rashmi Chugh; Laurence Baker
Journal:  Oncology (Williston Park)       Date:  2004-05       Impact factor: 2.990

Review 8.  Biology and therapy of pediatric rhabdomyosarcoma.

Authors:  A S Pappo; D N Shapiro; W M Crist; H M Maurer
Journal:  J Clin Oncol       Date:  1995-08       Impact factor: 44.544

9.  The role of radiotherapy in the management of localized soft tissue sarcomas.

Authors:  Siaw Sze Tiong; Colleen Dickie; Rick L Haas; Brian O'Sullivan
Journal:  Cancer Biol Med       Date:  2016-09       Impact factor: 4.248

10.  Rhabdomyosarcoma of the breast - a rare malignancy.

Authors:  Suresh J Bhosale; Ashok Y Kshirsagar; Soniya R Sulhyan; Sanjitsingh R Sulhyan
Journal:  Am J Case Rep       Date:  2013-07-15
View more
  1 in total

1.  Primary Rhabdomyosarcoma of the Breast: Study of Three Cases at One Institution with a Review of Primary Breast Sarcomas.

Authors:  Junyoung Shin; Hee Jeong Kim; Dae-Yeon Kim; Gyungyub Gong; Kyung-Ja Cho
Journal:  J Pathol Transl Med       Date:  2019-08-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.